نتایج جستجو برای: guérin bcg

تعداد نتایج: 9027  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2000
M A Horwitz G Harth B J Dillon S Maslesa-Galic'

Tuberculosis (TB) continues to ravage humanity, causing 2 million deaths per year. A vaccine against TB more potent than the current live vaccine, bacillus Calmette-Guérin (BCG), is desperately needed. Using two commercially available strains of BCG as host strains, BCG Connaught and Tice, we have constructed two recombinant BCG vaccines stably expressing and secreting the 30-kDa major secretor...

Journal: :Infection and immunity 2005
S de Vallière G Abate A Blazevic R M Heuertz D F Hoft

We investigated the ability of human antibodies induced by Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccination to protect against mycobacterial infections. Serum samples containing mycobacterium-specific antibodies were obtained from volunteers who had received two intradermal BCG vaccinations 6 months apart. Significant increases in lipoarabinomannan (LAM)-specific immunoglobulin G ...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2007
Roland Brosch Stephen V Gordon Thierry Garnier Karin Eiglmeier Wafa Frigui Philippe Valenti Sandrine Dos Santos Stéphanie Duthoy Céline Lacroix Carmen Garcia-Pelayo Jacqueline K Inwald Paul Golby Javier Nuñez Garcia R Glyn Hewinson Marcel A Behr Michael A Quail Carol Churcher Bart G Barrell Julian Parkhill Stewart T Cole

To understand the evolution, attenuation, and variable protective efficacy of bacillus Calmette-Guérin (BCG) vaccines, Mycobacterium bovis BCG Pasteur 1173P2 has been subjected to comparative genome and transcriptome analysis. The 4,374,522-bp genome contains 3,954 protein-coding genes, 58 of which are present in two copies as a result of two independent tandem duplications, DU1 and DU2. DU1 is...

Journal: :The Journal of infectious diseases 2009
Nazma Mansoor Thomas J Scriba Marwou de Kock Michele Tameris Brian Abel Alana Keyser Francesca Little Andreia Soares Sebastian Gelderbloem Silvia Mlenjeni Lea Denation Anthony Hawkridge W Henry Boom Gilla Kaplan Gregory D Hussey Willem A Hanekom

BACKGROUND Worldwide, most infants born to mothers infected with human immunodeficiency virus (HIV) receive bacille Calmette-Guérin (BCG) vaccine. Tuberculosis is a major cause of death among infants infected with HIV in sub-Saharan Africa, and it should be prevented. However, BCG may itself cause disease (known as "BCGosis") in these infants. Information regarding the immunogenicity of BCG is ...

2015
Nicolas Bruffaerts Lasse E. Pedersen Gaëlle Vandermeulen Véronique Préat Norbert Stockhofe-Zurwieden Kris Huygen Marta Romano Ann Rawkins

The only tuberculosis vaccine currently available, bacille Calmette-Guérin (BCG) is a poor inducer of CD8(+) T cells, which are particularly important for the control of latent tuberculosis and protection against reactivation. As the induction of strong CD8(+) T cell responses is a hallmark of DNA vaccines, a combination of BCG with plasmid DNA encoding a prototype TB antigen (Ag85A) was tested...

Journal: :Research and reports in urology 2015
Karel Decaestecker Willem Oosterlinck

This paper provides recommendations on the management of complications arising from intravesical treatment with bacillus Calmette-Guérin (BCG) for nonmuscle-invasive bladder tumors. There is minimal recommendations currently available as randomized trials on the side effects of intravesical BCG are lacking and severe complications are usually described in case reports only. All physicians givin...

2017
Junbao Yang Maris S. Jones Romela Irene Ramos Alfred A. Chan Agnes F. Lee Leland J. Foshag Peter A. Sieling Mark B. Faries Delphine J. Lee

Mycobacterium bovis bacille Calmette-Guérin (BCG) is listed as an intralesional (IL) therapeutic option for inoperable stage III in-transit melanoma in the National Comprehensive Cancer Network Guidelines. Although the mechanism is unknown, others have reported up to 50% regression of injected lesions, and 17% regression of uninjected lesions in immunocompetent patients after direct injection o...

Journal: :iranian journal of public health 0
n parvaneh dept. of pediatrics, infectious disease research center, children's medical center, tehran universit b pourakbari dept. of pediatrics, infectious disease research center, children's medical center, tehran universit kh daneshjoo dept. of pediatrics, imam khomeini hospital, tehran university of medical sciences, iran h ashraf dept. of pediatrics, infectious disease research center, children's medical center, tehran universit a salavati dept. of pediatrics, infectious disease research center, children's medical center, tehran universit s mamishi dept. of pediatrics, infectious disease research center, children’s medical center, tehran universit

background: cytokines and specially interferon-gamma (ifn-g) are largely responsible for the regulation of the protective im­mune response against mycobacterial infections. several studies have clarified the importance of common variants of ifn- g gene regarding the susceptibility to tuberculosis. bacille calmette-guérin (bcg) vaccine that is used to prevent se­vere forms of tuberculosis could ...

2018
Sofie Biering-Sørensen Kristoffer Jarlov Jensen Ivan Monterio Henrik Ravn Peter Aaby Christine Stabell Benn

Background Three randomized trials (RCTs) in low-weight (<2.5 kg) infants have shown that Bacille Calmette-Guérin (BCG) vaccine nonspecifically reduces all-cause mortality in the neonatal period. Methods Using data from 3 RCTs of early BCG (n = 6583) we examined potential sex differences in the timing of the mortality reduction in the neonatal period, presenting metaestimates of the main outc...

Journal: :Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2010
Douglas S Kernodle

Mutations that arose in bacille Calmette-Guérin (BCG) daughter strains during decades of in vitro cultivation have long been suspected of reducing the efficacy of the BCG vaccine against pulmonary tuberculosis. Although concern was raised 6 decades ago that BCG had become overattenuated, preferential use of relatively virulent BCG vaccines has not restored efficacy. The recent discovery that as...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید